GirardP-M, LandmanR, GaudeboutC, LepretreA, LottinP, MichonC, . Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine-treated AIDS patients. Lancet1989;1:1348–1353.
2.
LeoungGS, FeigalDWJr, MontgomeryAB, CorkeryK, WardlawL, AdamsM, . Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia: the San Francisco community prophylaxis trial. N Engl J Med1990;323:769–775.
3.
ConteJE, HollanderH, GoldenJA. Inhaled or reduced-dose intravenous pentamidine for Pneumocystis carinii pneumonia. Ann Intern Med1987;107:495–498.
4.
Centers for Disease Control. Mycobacterium tuberculosis transmission in a health clinic—Florida, 1988. MMWR1989;38:256–264.
5.
Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis to health care workers and HIV-infected patients in an urban hospital—Florida. MMWR1990;39:718–722.
6.
ChaissonRE, SlutkinG.Tuberculosis and HIV infection. J Infect Dis1989;159:96–100.
7.
MontgomeryAB, DebsRJ, LuceJM, CorkeyKJ, TurnerJ, BurnetteEN, . Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Lancet1987;2:480–483.
8.
Toronto Aerosolized Pentamidine Study (TAPS) Group. Acute pulmonary effects of aerosolized pentamidine: a randomized controlled study. Chest1990;98:907–910.
9.
SelwynPA, HartelD, LewisVA, SchoenbaumEE, VermundSH, KleinRS, . A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med1989;320:545–550.
10.
Di PerriG, CrucianiM, DanziMC, LuzzatiR, DeChecchiG, MalenaM, . Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet1989;2:1502–1504.
11.
Centers for Disease Control. Cases of specific notifiable diseases, United States, weeks ending December 1, 1990 and December 2, 1991 (48th week). MMWR1990;39:919.
12.
JohnsonMP, ChaissonRE. Tuberculosis and HIV disease. In: JacobsonMA, VolberdingPA, editors. AIDS clinical review 1991. New York: Marcel Dekker, 1991:109–126.
13.
ChaissonRE, SchecterGF, TheuerCP, RutherfordGW, EchenbergDF, HopewellPC. Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, response to therapy and outcome. Am Rev Respir Dis1987;136:570–574.
14.
SunderamG, McDonaldRJ, ManiatisT, OleskeJ, KapilaR, ReichmanLB. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA1986;256:362–366.
15.
BraunMM, TrumanBI, MaguireB, DiFerdinandoGTJr, WormserG, BroaddusR, . Increasing incidence of tuberculosis in a prison inmate population: association with HIV infection. JAMA1989;261:393–397.
16.
JohnsonM, ClermontHC, CoberlyJ, ChaissonR, DaviesH, EatonA, . Impact of HIV infection on response to tuberculin skin tests in Haitian adults (abstract). Am Rev Respir Dis1991;143(4, Part 2):A280.
17.
WellsWF. Aerodynamics of droplet nuclei. In: WellsWF, editor. Airborne contagion and air hygiene. Cambridge: Harvard University Press, 1955:13–19.
18.
HopewellPC. Factors influencing the transmission and infectivity of Mycobacterium tuberculosis: implications for clinical and public health practice. In: SandeMA, HudsonLD, RootRK, editors. Contemporary issues in infectious disease. Vol 5. New York: Churchill Livingstone, 1986:191–216.
19.
LoudonRG, SpohnSK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis1969;99:109–112.
20.
GrzybowskiS, BarnettGD, StybloK.Contacts of cases of active pulmonary tuberculosis. Bull Int Union Against Tuberc1975;60:90.
21.
RileyRL, MillsCC, O'GradyF, SultanLU, WittstadtF, ShivpuriDN. Infectiousness of air from a tuberculosis ward. Am Rev Respir Dis1962;85:511–525.
22.
JindaniA, AberVR, EdwardsEA, MitchisonDA. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis1980;121:939–949.
23.
KantorHS, PobleteR, PusatreiSL. Nosocomial transmission of tuberculosis from unsuspected disease. Am J Med1988;84:833–838.
24.
ElliottAM, LuoN, TemboG, HalwiindiB, SteerbergenG, MachielsL, . Impact of HIV on tuberculosis in Zambia: a cross-sectional study. Br Med J1990;301:412–415.
25.
KleinNC, DuncansonFP, LenoxTHIII, PittaA, CohenSC, WormserGP. Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest1989;95:1190–1192.
26.
SmallPM, SchecterGF, GoodmanPC, SandeMA, ChaissonRE, HopewellPC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med1991;324:289–294.
27.
ChaissonRE. Prevention of opportunistic infections in patients with HIV infection. Maryland Med J1990;39(2):156–160.
28.
Centers for Disease Control. Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR1990;39(RR-17):1–29.
29.
BraunMM, BadiN, RyderRW, BaendeE, MukadiY, NsuamiM, . A retrospective cohort study of the risk of tuberculosis among women of childbearing age with HIV infection in Zaire. Am Rev Respir Dis1991;143:501–504.
30.
BatungwanagoJ, AllenS, BogaertsJ, . Etude prospective du risque de tuberculose dans une cohorte de femmes HIV seropositives a Kigali, Rwanda (abstract WOD4). Kinshasa, Africa: Fifth International Conference on AIDS and Malignancies in Africa, Oct 10, 1990.
31.
Centers for Disease Control. Diagnosis and management of mycobacterial infection and disease in persons with human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR1986;35:448–452.
32.
Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR1989;38:236–238,243-250.
33.
WadhawanD, HiraS, MwansaN, TemboG, PerinePL. Isoniazid prophylaxis among patients with HIV-1 infection (abstract No. Th.B.510). San Francisco: Sixth International Conference on AIDS, June 21-24, 1990.
34.
LecoeurHF, Truffot-PernotC, GrossetJH. Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide. Am Rev Respir Dis1989;140:1189–1193.
35.
MacDonellKB, ChmielJS, GoldsmithJ, WallemarkCB, SteinbergJ, ByrersE, . Prognostic usefulness of the Walter Reed staging classification for HIV infection. J AIDS1988;1(4):367–374.
36.
HopewellPC. Diagnosis of Pneumocystis carinii pneumonia. Infect Dis Clin North Am1988;2:409–418.
RileyRL. Airborne infection. Am J Med1974;57:466–475.
39.
American Society of Heating, Refrigerating, and Air Conditioning Engineers. 1987 ASHRAE handbook: heating, ventilating, and air-conditioning systems and applications. Atlanta: ASHRAE, 1987;23:1–12.
40.
RileyRL, NardellEA. Clearing the air: the theory and application of UV air disinfection. Am Rev Respir Dis1989;139:1286–1294.
41.
WellsWF, WellsMW, WilderTS. The environmental control of epidemic contagion: I. An epidemiologic study of radiant disinfection of air in days schools. Am J Hygiene1942;35:97–121.
42.
PippinDJ, VerderameRA, WeberKK. Efficacy of face masks in preventing inhalation of airborne contaminants. J Oral Maxillofac Surg1987;45:319–323.